Vice President - Discovery and Developmental Sciences @ Oncobiologics Inc. (January 2011 - January 2015)
Executive Director - Analytical Sciences @ (January 2004 - August 2010)
Director - Analytical Sciences @ (January 2000 - January 2004)
Senior Research Scientist @ (January 1999 - January 2000)
John Cini Education
University of North Texas
PhD (Biochemistry / Aging)
John Cini Skills
21 CFR Part 11
Antibodies
Assay Development
Biochemistry
Biomarker Discovery
Biomarkers
Biopharmaceuticals
Biotechnology
CRO
Cancer
Cell
Cell Biology
Cell Culture
Characterization
Clinical Development
Clinical Research
Clinical Trials
Commercialization
Drug Development
Drug Discovery
FDA
Formulation
GCP
GLP
GMP
HPLC
Immunology
Infectious Diseases
Leadership
Lifesciences
Microbiology
Molecular Biology
Oncology
Patents
Pharmaceutical Industry
Pharmaceutics
Pharmacology
Protein Chemistry
R&D
Regulatory Affairs
Regulatory Submissions
Science
Sop
Technology Transfer
Vaccines
Validation
Microsoft Office
Marketing
Customer Service
Startups
John Cini Summary
John Cini, based in New York, NY, US, is currently a Chief Scientific Officer and Co-Founder at Sonnet BioTherapeutics, Inc.. John Cini brings experience from previous roles at SonnetBioTherapeutics, Oncobiologics Inc. and Medarex. John Cini holds a PhD in Biochemistry / Aging @ University of North Texas. With a robust skill set that includes 21 CFR Part 11, Antibodies, Assay Development, Biochemistry, Biomarker Discovery and more. John Cini has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different John Cini?
Find contact details for 700 million professionals.